Tatjana Sipetic graduated from the Faculty of Pharmacy, Belgrade University in 1997. She specialized in Pharmacoeconomy and Pharmaceutical Legislation from the same Faculty in 2006. She gained professional experience while working in private practice in the period 1997-2005. From 2005 to 2009 she was the head of the hospital pharmacy at the Clinical Hospital Centre Dr Dragisa Misovic. In the period 2001-2006 she worked as an assistant professor of Toxicological Chemistry, Pharmacy Department, School of Medicine, University of Banjaluka. She was appointed Director of Medicines and Medical Devices Agency of Serbia in July 2009. She attended various educational programmes in hospital pharmacy, public health and health management.

Dr. Di Giorgio is Chairman of the EDQM/CoE “Committee of experts on minimising public health risks posed by counterfeiting of medical products and related crimes” and “European Committee on Pharmaceuticals and Pharmaceutical Care”: coordinator and member of the organizing committee of the AIFA-WHO international conference “Combating Counterfeit Drugs” (Rome, 2006); Italian member and Rapporteur of IMPACT; Consultant of the Italian Senate (e-pharmacies and counterfeit medicines).

Martin is the Legal Director for the European Association of Pharmaceutical Full-line Wholesalers (GIRP). GIRP is the European association which is headquartered in Brussels (Belgium) and brings together the over 600 pharmaceutical full-line wholesaling companies and their national associations from 31 European countries. Martin advises the association on the matrix of legal issues impacting upon the interests of the pharmaceutical full-line wholesale sector in Europe. He also represents the association externally European institutions as well as with other European and International organisations such as the Council of Europe and the WHO and national authorities.

Kristian Bartholin is the coordinator on medical crimes in the Criminal Law Division of
the Directorate of Standard-Setting, Council of Europe. He was the secretary to the various expert bodies and committees which prepared the draft Council of Europe Convention on Counterfeiting of Medical Products and Similar Crimes involving Threats to Public Health, which will be adopted by the Council of Europe in 2010.

Dr Siniša Tomić is Head of the Agency for Medicinal Products and Medical Devices of the Republic of Croatia. Dr Tomić studied medical biochemistry at the University of Zagreb and received his Ph.D. in Biochemistry at the Friedrich Schiller University of Jena in 1996. From 1996 to 1999 he completed his postdoctoral research in the field of pharmaceutical biotechnology at the National Research Council of Canada and McGill University in Montréal. He was Max Planck Society Fellow and Canadian Government Visiting Fellow. From 1999 he worked at the Ministry for European Integration and in 2001 moved to Rijeka and worked for pharmaceutical industry. In 2003 he is back to Zagreb to take over as head of the newly established Croatian Agency for Medicinal Products and Medical Devices. Dr Tomić lectures courses in regulatory affairs at graduate and undergraduate level at Universities of Rijeka and Osijek and presides over the Regulatory section of the Croatian Pharmaceutical Society.

Daniel Ghinn co‐founded Creation Interactive, the engagement strategy consultancy for healthcare and government, in 1998. The London-based consultancy provides independent advice and strategy implementation that helps leaders and communicators in healthcare and government to achieve successful digital media initiatives with measurable results. Today, Creation Interactive is recognised as a leading international advisor on digital engagement to pharmaceutical and healthcare companies.
Prior to launching Creation Interactive in 1998, Daniel’s career included a role in pharmaceutical intelligence with Medicare Audits (later to become IMS Health) where he worked with international pharmaceutical clients to gain marketing insights from prescriber activity analysis. Daniel has spent the last seventeen years helping people to achieve goals using technology and the Internet.
He is Chairman of Kent Invicta Chamber of Commerce, which represents the business community in Kent where he lives. Daniel also contributes to education initiatives, economic development and community planning forums, and has been a speaker at numerous education and business events.

Maren Jergolla is a Senior Associate at Wolf Theiss and admitted to the bar in Germany. In Austria, she is currently registered in the list of the European Attorneys with the Vienna Bar Association and will be admitted to the bar in Austria presumably as of February 2010. Before she moved to Vienna and joined Wolf Theiss in 2005, she received her LL.M. degree in Cambridge, UK, and has worked 4 years as a research assistant at the department of IP law at the University of Mannheim, Germany.
At Wolf Theiss, Maren Jergolla specializes in the following legal fields: Life Science, in particular pharmaceutical and medical device law, including advertising law; Unfair Competition Law, in particular advertising law, law on sales promotions and law on product imitations; Intellectual Property, in particular trade mark law, design law, copyright law, and anti-counterfeiting; licensing and distribution law; Litigation. Renowned global entreprises such as Novartis, Biogen Idec, Covidien, Volcano, Crocs and Hairdreams rely upon her in-depth expertise.

Mathieu Aman, Logistics Manager within Pharma Technical Operations at the Roche HQ in Basel, is responsible of a global Roche project called "Supply chain control", aiming to implement serialization and tracking and tracing requirements on a Roche global level. He hold various positions within supply chain management within the Roche Group since 1993 and is member of the EFPIA "Coding and Identification" task force as a Senior Oversight Group member as well as member of the Senior Expert Group II (Supply chain and distribution).

After Physics and Technical Education studies at the University of Zagreb, Croatia, Stjepan joined Crystallography group at the Laboratory of General & Inorganic Chemistry, Univ. of Zagreb as X-ray Instrumentation Specialist. One of main group’s interest area was structural characterization of pharmaceutically interesting materials by means of X-ray diffraction (XRD) After 7 years at the University, Stjepan joined PANalytical (at that time Philips Analytical) in 1998 as Regional Customer Support Manager for Asia-Pacific region, based in Singapore. Since 2001 in the position of Regional Product Manager XRD with the focus on pharma-specific applications and solutions within the EMEA region. In addition to EMEA XRD product management, since 2008 has had overall responsible for PANalytical business activities in the Eastern Europe.

Mr. Marjan Poljak is a senior associate at Karanovic & Nikolic law firm, a leading Belgrade based law firm with offices in Serbia, Montenegro, Bosnia and Macedonia. He is registered as an attorney at the Belgrade Bar Association. From 2002 Mr. Poljak worked as an associate and subsequently as a senior lawyer in commercial law firms in Serbia. Mr. Poljak has extensive experience in advising clients on all aspects of commercial law and in particular has gained expertise in pharmaceutical law and healthcare matters. Mr. Poljak advises clients on wide-ranging regulatory and commercial issues with respect to pharmaceutical and healthcare matters including market authorizations, advertising and clinical trial performance. He is a member of the International Bar Association and a regular contributer to international publications in his fields of expertise. Mr. Poljak was a member of the team in numerous cases and transactions in the field of corporate and healthcare law in Serbia and Montenegro.

Antony Taubman is currently Director, Intellectual Property Division, World Trade Organization, with responsibility for intellectual property, competition and government procurement.
From 2002 to 2009, he was Director, Global Intellectual Property Issues Division (including the Traditional Knowledge Division and Life Sciences Program of WIPO, covering a wide range of programs on intellectual property and genetic resources, traditional knowledge and folklore, the life sciences, and related global issues including the environment, climate change, human rights, food security, bioethics and indigenous issues.
After a diplomatic career, he left the Australian Department of Foreign Affairs and Trade (DFAT) in 2001 to join the newly-formed Australian Centre for Intellectual Property in Agriculture, at the Australian National University, teaching and researching on international IP law.
From 1998 to 2001, he was Director of the International Intellectual Property Section of DFAT, and in that capacity was engaged in multilateral and bilateral negotiations on intellectual property issues, domestic policy development, regional cooperation, and TRIPS dispute settlement. He has taken part in many training and capacity building programs on intellectual property law and TRIPS in Australia and a number of Asian countries.
In 2008, the Rockefeller Foundation awarded him a Bellagio residential fellowship for his work on TRIPS and public policy issues. He joined DFAT in 1988 as a career diplomat, and his service included disarmament policy and participation in the negotiations on the Chemical Weapons Convention.
He previously worked for WIPO from 1995 to 1998, his duties then including development cooperation in Asia and the Pacific, the development of the revised WIPO program and budget, and associated policy development. A registered patent attorney, he worked in private practice in the law of patents, trade marks and designs in Melbourne in the 1980s. His tertiary education has included computer science, mathematics, engineering, classical languages, philosophy, international relations and law, including two academic prizes for postgraduate law from the University of Edinburgh, and he has taught ancient Greek philosophy at Melbourne University.